Word

OXAPEX

Status

Registered

Status Code

700

Status Date

Tuesday, July 12, 2022

Serial Number

87780730

Registration Number

6784317

Registration Date

Tuesday, July 12, 2022

Mark Type

4000

Filing Date

Thursday, February 1, 2018

Published for Opposition

Tuesday, April 26, 2022

Trademark Owner History

FIRST GAIN INTERNATIONAL LIMITED - Original Registrant
Hong Kong Cytogenetics and Medical Genetics Centre Limited - Original Applicant

Classifications

5 Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposes, namely, sterile solutions for use in oxygen therapeutics for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; biological preparations for medical and veterinary purposes, namely, hemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; Biological preparations for medical and veterinary purposes, namely, protein arrays, biological tissue cultures, blood, blood plasma, and blood serums for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases

Trademark Events

Jul 12, 2022

Notice Of Registration Confirmation Emailed

Jul 12, 2022

Registered-Principal Register

Apr 26, 2022

Official Gazette Publication Confirmation E-Mailed

Apr 26, 2022

Published For Opposition

Apr 6, 2022

Notification Of Notice Of Publication E-Mailed

Mar 10, 2022

Notice Of Allowance Cancelled

Mar 9, 2022

Attorney Review/Decision On Amendment Required

Mar 9, 2022

Petition To Director - Change Basis - Granted

Mar 7, 2022

Assigned To Petition Staff

Feb 25, 2022

Teas Petition To Amend Basis Received

Feb 18, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 17, 2022

Sou Extension 5 Granted

Feb 10, 2022

Sou Extension 5 Filed

Feb 17, 2022

Case Assigned To Intent To Use Paralegal

Feb 10, 2022

Teas Extension Received

Aug 25, 2021

Notice Of Approval Of Extension Request E-Mailed

Aug 23, 2021

Sou Extension 4 Granted

Aug 23, 2021

Sou Extension 4 Filed

Aug 23, 2021

Teas Extension Received

Feb 20, 2021

Notice Of Approval Of Extension Request E-Mailed

Feb 18, 2021

Sou Extension 3 Granted

Feb 18, 2021

Sou Extension 3 Filed

Feb 18, 2021

Teas Extension Received

Aug 15, 2020

Notice Of Approval Of Extension Request E-Mailed

Aug 13, 2020

Sou Extension 2 Granted

Aug 13, 2020

Sou Extension 2 Filed

Aug 13, 2020

Teas Extension Received

Feb 27, 2020

Notice Of Approval Of Extension Request E-Mailed

Feb 25, 2020

Sou Extension 1 Granted

Feb 25, 2020

Sou Extension 1 Filed

Feb 25, 2020

Teas Extension Received

Sep 3, 2019

Noa E-Mailed - Sou Required From Applicant

Jul 9, 2019

Official Gazette Publication Confirmation E-Mailed

Jul 9, 2019

Published For Opposition

Jun 19, 2019

Notification Of Notice Of Publication E-Mailed

Jun 6, 2019

Approved For Pub - Principal Register

Jun 6, 2019

Examiner's Amendment Entered

Jun 6, 2019

Notification Of Examiners Amendment E-Mailed

Jun 6, 2019

Examiners Amendment E-Mailed

Jun 6, 2019

Examiners Amendment -Written

May 30, 2019

Report Completed Suspension Check Case Still Suspended

Feb 20, 2019

Automatic Update Of Assignment Of Ownership

Nov 20, 2018

Notification Of Letter Of Suspension E-Mailed

Nov 20, 2018

Letter Of Suspension E-Mailed

Nov 20, 2018

Suspension Letter Written

Nov 19, 2018

Teas/Email Correspondence Entered

Nov 19, 2018

Correspondence Received In Law Office

Nov 15, 2018

Teas Response To Office Action Received

May 15, 2018

Notification Of Non-Final Action E-Mailed

May 15, 2018

Non-Final Action E-Mailed

May 15, 2018

Non-Final Action Written

May 15, 2018

Assigned To Examiner

Mar 7, 2018

Preliminary/Voluntary Amendment - Entered

Mar 5, 2018

Assigned To Lie

Feb 20, 2018

Teas Voluntary Amendment Received

Feb 11, 2018

New Application Office Supplied Data Entered In Tram

Feb 5, 2018

New Application Entered In Tram